Metabolic and bariatric surgery in 2026 faces a strategic fork in the road. On one path we insist that surgery as the best option for weight loss – full stop. The other positions surgery as an essential tool for achieving optimal health in people living with obesity. How we choose to frame the value of surgery matters – not just for surgeons – but for patients and everyone who cares about obesity and metabolic health.

Interpreting Recent Studies

Recent studies have spotlighted the striking acute outcomes associated with bariatric and metabolic surgery. One such study recently appeared in Annals of Internal Medicine. In a retrospective analysis, researchers found better outcomes for surgical treatment of obesity and diabetes than for either medical or lifestyle treatment. The study pitted surgery against each of the other modalities. Headlines from this study declared: “Bariatric surgery beats GLP-1s.”

We get it. It’s tempting to lean heavily on such comparisons. A steady stream of them is flowing these days. However, in stressing the superiority of surgical outcomes we risk missing the forest for the trees.

Treating obesity is not a one and done proposition.

The Perspective of People Living with Obesity

For many patients, the numbers on a scale or the percent of excess weight lost tell only part of the story. People living with obesity bring their own diverse experiences, personal priorities, and real-world constraints to decisions about care. To some, surgery is an option they readily embrace. But others are deeply averse to surgery. They may have conditions or life circumstances that make surgery risky or less appealing. Some see pharmacotherapy as a lifeline that can improve health, function, and quality of life – without the invasiveness of an operation. Many of them will need multiple modalities of care.

To paint the choice as surgery versus medicines is to create a false and misleading dichotomy. Such a dichotomy is just as absurd as it would be to present patients with a choice between medicine and surgery for cancer care.

Liz Paul, who is Vice Chair of the Obesity Action Coalition, explains the importance of this:

“When I advocate for people seeking obesity care, my emphasis is always comprehensive care. We need both/and, not either/or. Respect for the lived experience and needs of patients must come first and that means honoring patient’s shared decisions for their care.”

The Rest of the Story

Obesity is a complex, chronic, and progressive disease. No single intervention – surgical, pharmacologic, or behavioral – will be the best for every person at every stage. Surgery is an incredibly powerful and essential tool, especially for those with advanced disease or serious comorbidities. But that power should not be wielded as a cudgel in a zero-sum argument.

If metabolic and bariatric surgeons are to lead in 2026 and beyond, we must resist the temptation to set up a competition for the title of “best therapy.” Patients deserve a seat at the table – where informed choice, clinical nuance, and the full continuum of care drive decisions with the aim of optimal long-term health.

Click here for the study in Annals, here and here for reporting on it. For further perspective, click here, here, and here.

Woman with a Fork in a Winter Landscape, sketch and study by Vincent van Gogh / WikiArt